Metronomic chemotherapy in head and neck cancer

被引：3

作者：

De Felice, Francesca ^{[1
]}

Benevento, Ilaria ^{[1
]}

Musella, Angela ^{[2
]}

Musio, Daniela ^{[1
]}

Tombolini, Vincenzo ^{[1
,3
]}

机构：

[1] Sapienza Univ Rome, Policlin Umberto 1, Dept Radiotherapy, Viale Regina Elena 326, I-00161 Rome, Italy

[2] Sapienza Univ Rome, Dept Gynecol Obstet & Urol Sci, Viale Regina Elena 326, I-00161 Rome, Italy

[3] Spencer Lorillard Fdn, Viale Regina Elena 262, Rome, Italy

来源：

CANCER LETTERS | 2017年 / 400卷

关键词：

Head neck cancer; Metronomic chemotherapy; Low dose; Survival; Recurrence; Treatment; SQUAMOUS-CELL CARCINOMA;

D O I：

10.1016/j.canlet.2016.10.047

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Head neck cancer (HNC) is generally treated with a multimodality approach. Loco-regional-distant control is often worst, due to the advantage stage disease at diagnosis and the optimal treatment option remains an unresolved issue. Metronomic chemotherapy (MCHT) is an emerging therapeutic option in clinical oncology and it may prove useful in HNC patients. (C) 2016 Elsevier Ireland Ltd. All rights reserved.

引用

页码：219 / 222

页数：4

共 24 条

[1] Models, mechanisms and clinical evidence for cancer dormancy [J].

Aguirre-Ghiso, Julio A. .

NATURE REVIEWS CANCER, 2007, 7 (11) :834-846

[2]

[Anonymous], 2016, National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN guidelines) Breast Cancer. Version I

[3] Metronomic Chemotherapy for Metastatic Breast Cancer - a Systematic Review of the Literature [J].

Banys-Paluchowski, M. ;

Schuetz, F. ;

Ruckhaeberle, E. ;

Krawczyk, N. ;

Fehm, T. .

GEBURTSHILFE UND FRAUENHEILKUNDE, 2016, 76 (05) :525-534

[4]

Browder T, 2000, CANCER RES, V60, P1878

[5]

Camphausen K, 2002, EXPERT OPIN BIOL TH, V2, P477

[6] Head and neck cancer: metronomic chemotherapy [J].

De Felice, Francesca ;

Musio, Daniela ;

Tombolini, Vincenzo .

BMC CANCER, 2015, 15

[7]

Edge S., 2010, AJCC cancer staging handbook: From the AJCC cancer staging manual

[8] Metronomic cyclophosphamide regimen selectively depletes CD4+ CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients [J].

Ghiringhelli, Francois ;

Menard, Cedric ;

Puig, Pierre Emmanuel ;

Ladoire, Sylvain ;

Roux, Stephan ;

Martin, Francois ;

Solary, Eric ;

Le Cesne, Axel ;

Zitvogel, Laurence ;

Chauffert, Bruno .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (05) :641-648

[9] Interaction between Tobacco and Alcohol Use and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium [J].

Hashibe, Mia ;

Brennan, Paul ;

Chuang, Shu-Chun ;

Boccia, Stefania ;

Castellsague, Xavier ;

Chen, Chu ;

Curado, Maria Paula ;

Dal Maso, Luigino ;

Daudt, Alexander W. ;

Fabianova, Eleonora ;

Fernandez, Leticia ;

Wuensch-Filho, Victor ;

Franceschi, Silvia ;

Hayes, Richard B. ;

Herrero, Rolando ;

Kelsey, Karl ;

Koifman, Sergio ;

La Vecchia, Carlo ;

Lazarus, Philip ;

Levi, Fabio ;

Lence, Juan J. ;

Mates, Dana ;

Matos, Elena ;

Menezes, Ana ;

McClean, Michael D. ;

Muscat, Joshua ;

Eluf-Neto, Jose ;

Olshan, Andrew F. ;

Purdue, Mark ;

Rudnai, Peter ;

Schwartz, Stephen M. ;

Smith, Elaine ;

Sturgis, Erich M. ;

Szeszenia-Dabrowska, Neonilia ;

Talamini, Renato ;

Wei, Qingyi ;

Winn, Deborah M. ;

Shangina, Oxana ;

Pilarska, Agnieszka ;

Zhang, Zuo-Feng ;

Ferro, Gilles ;

Berthiller, Julien ;

Boffetta, Paolo .

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (02) :541-550

[10] Metronomic chemotherapy in recurrent head and neck cancer. [J].

Mateen, Abdul ;

Adil, Allah Rakha ;

Maken, Rab Nawaz ;

Khan, Shahbaz Ahmad ;

Arif, Muhammad .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)

← 1 2 3 →